--- title: "Metformin vs Rapamycin: Side-by-Side Comparison (2026)" description: "Compare Metformin vs Rapamycin — mechanism, half-life, dose range, side effects, and live vendor pricing. Side-by-side data from BodyHackGuide — we earn a" lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compare", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "Metformin vs Rapamycin" } ] }, { "@context": "https://schema.org", "@type": "WebPage", "name": "Metformin vs Rapamycin: Side-by-Side Comparison (2026)", "description": "Compare Metformin vs Rapamycin — mechanism, half-life, dose range, side effects, and live vendor pricing. Side-by-side data from BodyHackGuide — we earn a commission on some vendor links.", "url": "https://www.bodyhackguide.co/compare/metformin-vs-rapamycin", "dateModified": "2026-09-07", "isPartOf": { "@type": "WebSite", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainEntity": { "@type": "ItemList", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@type": "Product", "name": "Metformin", "description": "Metformin is a biguanide-class oral antihyperglycemic medication that has been in continuous clinical use since 1957 (in France under the brand name Glucophage) and is now the most-prescribed diabetes medication worldwide with over 150 million prescriptions annually. Structurally…", "url": "https://www.bodyhackguide.co/compound/metformin", "category": "Metabolic" } }, { "@type": "ListItem", "position": 2, "item": { "@type": "Product", "name": "Rapamycin", "description": "Rapamycin is a macrocyclic lactone antibiotic discovered in 1972 in soil samples from Rapa Nui (Easter Island) by a bacteriology survey team investigating indigenous Streptomyces species. Named after its place of discovery, rapamycin was initially developed as an antifungal agent before its…", "url": "https://www.bodyhackguide.co/compound/rapamycin", "category": "Longevity" } } ] } }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What's the difference between Metformin and Rapamycin?", "acceptedAnswer": { "@type": "Answer", "text": "Metformin is a metabolic that metformin's molecular mechanism of action has been progressively elucidated over decades and now involves multiple overlapping pathways, though which pathway dominates in any given…. Rapamycin is a longevity that rapamycin's mechanism of action centers on its inhibition of the mechanistic target of rapamycin (mtor), a central serine-threonine kinase that integrates nutrient, growth factor,…. The two differ in mechanism, half-life (not reported vs not reported), and typical dose range." } }, { "@type": "Question", "name": "Which has the longer half-life, Metformin or Rapamycin?", "acceptedAnswer": { "@type": "Answer", "text": "Metformin has a half-life of not reported. Rapamycin has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics." } }, { "@type": "Question", "name": "Can you stack Metformin and Rapamycin?", "acceptedAnswer": { "@type": "Answer", "text": "Stacking depends on mechanism overlap, safety profile, and goals. Metformin and Rapamycin should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds." } }, { "@type": "Question", "name": "Is rapamycin actually proven to extend lifespan in humans?", "acceptedAnswer": { "@type": "Answer", "text": "Not yet. The mouse data is the strongest in geroscience — +9-26% median lifespan across NIA ITP studies, replicable across labs. But the only formal human RCT (PEARL, 2023, 130 adults, 1 year) measured safety + biomarkers + physical performance, not lifespan. A formal human lifespan trial would need decades + thousands of participants and doesn't currently exist. Geroscience consensus: mouse data is suggestive but not proof." } }, { "@type": "Question", "name": "Can I take metformin and rapamycin together?", "acceptedAnswer": { "@type": "Answer", "text": "Yes — this is the most common longevity stack (Attia, Sinclair, Kaeberlein protocols). Metformin daily 500-1000 mg + rapamycin 5-6 mg once weekly. They hit different points in the same pathway (AMPK + mTORC1) and have additive autophagy effects. No major drug-drug interaction concerns. Get quarterly labs while stacking: CBC, lipid panel, fasting glucose, creatinine, B12." } }, { "@type": "Question", "name": "Why is rapamycin dosed once weekly for longevity but daily for transplants?", "acceptedAnswer": { "@type": "Answer", "text": "Daily rapamycin inhibits BOTH mTORC1 (the longevity-relevant target) and mTORC2 (which controls insulin signaling + glucose metabolism). Chronic mTORC2 inhibition is what drives the metabolic side effects in transplant patients (hyperglycemia, lipid elevation). Weekly pulse dosing — 5-6 mg every 7 days — inhibits mTORC1 enough to trigger autophagy benefits while letting mTORC2 recover between doses. PEARL trial data supports this approach as safe over 1 year." } }, { "@type": "Question", "name": "What's the deal with metformin blunting exercise adaptations?", "acceptedAnswer": { "@type": "Answer", "text": "A 2019 study (Konopka et al., Aging Cell) showed metformin reduced mitochondrial respiration improvements in older adults doing aerobic training. The effect is modest (~20% reduction in some adaptation markers) and may not apply to younger users or strength training. Practical workaround for longevity users who train hard: take metformin on non-training days, or split the dose so the post-workout window is metformin-free. Other longevity drugs (rapamycin, NMN) don't show this exercise-blunting effect." } }, { "@type": "Question", "name": "Does rapamycin suppress the immune system?", "acceptedAnswer": { "@type": "Answer", "text": "At immunosuppression doses (2-5 mg/day) — yes, that's the indication. At weekly longevity doses (5-6 mg once/week) — minimally per PEARL trial. Some users report slight increase in mouth sores or mild fatigue around dose day. If you're getting frequent infections or wound healing slows visibly, that's a signal to drop the dose or pause. People on chemotherapy, recent surgery, or with chronic infections shouldn't be on longevity-dose rapamycin without physician oversight." } }, { "@type": "Question", "name": "Is berberine a real metformin substitute?", "acceptedAnswer": { "@type": "Answer", "text": "Partially. Berberine also activates AMPK and improves insulin sensitivity, but at ~1/3 the potency of metformin per gram. Typical dose: 500 mg 2-3×/day. Pros: no prescription needed, fewer GI side effects long-term. Cons: weaker glucose-lowering effect (HbA1c reduction ~0.5% vs metformin's ~1.5%), lacks the 60-year safety database. Reasonable choice for users who can't tolerate metformin or want an OTC option, but for confirmed prediabetes or T2D, metformin remains the higher-evidence pick." } } ] } ] --- [Skip to content](#main-content) ## Research Use Only This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. BodyHackGuide and **BHG Labs share common ownership**; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy). I'm 21+ — Enter SiteLeave site [![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/) [Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools) Learn Community Search ⌘K [Sign In](/auth?returnTo=%2Fcompare%2Fmetformin-vs-rapamycin) 100K+ researchers trust BodyHackGuide — Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) 1. [Home](/) 2. [Compare](/compare) 3. Metformin vs Rapamycin # Metformin vs Rapamycin Side-by-side comparison of Metformin and Rapamycin: mechanism, half-life, dose range, safety profile, and live vendor pricing. Updated continuously as new research and listings land. ## Live price snapshot ### Metformin ### Rapamycin ## Metformin Metformin is a biguanide-class oral antihyperglycemic medication that has been in continuous clinical use since 1957 (in France under the brand name Glucophage) and is now the most-prescribed diabetes medication… [Full Metformin profile](/compound/metformin) ## Rapamycin Rapamycin is a macrocyclic lactone antibiotic discovered in 1972 in soil samples from Rapa Nui (Easter Island) by a bacteriology survey team investigating indigenous Streptomyces species. Named after its place of… [Full Rapamycin profile](/compound/rapamycin) ## Side-by-side comparison Attribute Metformin Rapamycin Category Metabolic Longevity Research Stage Preclinical Preclinical Mechanism of Action Metformin's molecular mechanism of action has been progressively elucidated over decades and now involves multiple overlapping pathways, though which pathway dominates in any given tissue context remains contested. The classical view centers on mitochondrial… Rapamycin's mechanism of action centers on its inhibition of the mechanistic target of rapamycin (mTOR), a central serine-threonine kinase that integrates nutrient, growth factor, and stress signals to regulate cellular growth, protein synthesis, autophagy,… Half-Life — — Typical Dose Range — — Dosing Frequency — — Administration — — Side Effects Metformin has a well-characterized side effect profile dominated by GI tolerability issues that are usually manageable and a rare but serious lactic acidosis risk that warrants attention in specific clinical contexts. Common GI side effects affect 20-30% of… Rapamycin has a well-characterized side-effect profile developed over decades of transplant use. The profile at longevity doses (weekly 5-8 mg) is substantially milder than at transplant doses (continuous daily dosing targeting 5-15 ng/mL trough levels), but… Molecular Weight — — Common Vial Sizes — — In-depth comparison ## Metformin vs Rapamycin: the long answer Metformin is a 60-year-old AMPK activator originally for type 2 diabetes; the TAME trial (~3,000 adults, readout expected 2027+) is the first formal human longevity RCT. Rapamycin is an mTORC1 inhibitor with the strongest mouse-lifespan data in geroscience (+9-26% across NIA ITP studies) but no human lifespan trial. For a longevity protocol in 2026, metformin is cheap + safe with decades of T2D safety data; rapamycin is more speculative, requires careful weekly dosing (PEARL protocol: 5-10 mg/week), and has stronger mechanistic but weaker human evidence. Last reviewed: May 18, 2026 ### Mechanism — AMPK activation vs mTORC1 inhibition These are two of the four canonical longevity pathways (the others are caloric restriction and sirtuin activation). Metformin works through partial inhibition of mitochondrial Complex I, which raises the AMP:ATP ratio and activates AMPK — the cellular energy sensor that flips on autophagy, fatty acid oxidation, and mitochondrial biogenesis while suppressing anabolism. Rapamycin works upstream of AMPK by directly inhibiting mTORC1, the master regulator of cellular growth. mTORC1 inhibition triggers autophagy + suppresses protein synthesis + reduces senescent cell burden. Both pathways converge on autophagy and improved cellular housekeeping, but rapamycin's effect is more direct and dose-dependent. - **Metformin:** Mitochondrial Complex I partial inhibitor → AMPK activator → autophagy + improved insulin sensitivity - **Rapamycin:** Direct mTORC1 inhibitor → autophagy + reduced senescent cell load + suppressed protein synthesis - **Pathway overlap:** Both converge on autophagy upregulation, but rapamycin hits mTORC1 directly while metformin works indirectly through AMP:ATP sensing ### Evidence — what the trials actually show Metformin has 60 years of T2D safety data plus the DPP trial showing a 31% reduction in T2D incidence in prediabetic adults (850 mg 2×/day, 2,766 participants, NEJM 2002). The TAME trial (Targeting Aging with Metformin), led by Nir Barzilai, is the first formal RCT testing metformin for healthspan/lifespan endpoints — ~3,000 adults aged 65-79, expected readout 2027+. Rapamycin has mouse data showing 9-26% lifespan extension across NIA Interventions Testing Program (ITP) studies, even when started late in life. In humans: PEARL trial (2023, 130 adults, Lloyd et al.) showed 5-10 mg/week rapamycin was safe + tolerated over 1 year with modest gains in lean mass and physical performance. No human lifespan or hard healthspan trial exists for rapamycin yet. - **Metformin DPP:** 31% T2D incidence reduction in prediabetic adults (2,766 participants, NEJM 2002) - **Metformin TAME:** First human longevity RCT; ~3,000 adults; readout expected 2027+ - **Rapamycin mouse:** +9-26% lifespan extension (NIA ITP studies, multiple cohorts) - **Rapamycin PEARL:** 5-10 mg/week safe + tolerated over 1 year in 130 adults; modest lean mass + performance gains ### Dosing — daily vs once-weekly Metformin is dosed 500-2000 mg/day for diabetes; longevity protocols (per Barzilai, Sinclair, et al.) typically run 500-1000 mg/day. Most users start at 500 mg with dinner to minimize GI side effects; can escalate to 1000 mg/day if tolerated. Extended-release (Glucophage XR) is gentler on the gut. Rapamycin's longevity dose is fundamentally different from its immunosuppression dose — transplant patients run 2-5 mg/day, but the geroscience consensus is 5-6 mg ONCE WEEKLY (PEARL protocol). The weekly pulse keeps mTORC2 (which controls insulin signaling) intact while still inhibiting mTORC1 (the longevity-relevant target). Some advanced users cycle 0.1-0.4 mg/kg every 1-2 weeks based on Matt Kaeberlein's protocol notes. - **Metformin longevity:** 500-1000 mg/day with food; XR formulation reduces GI side effects - **Rapamycin PEARL:** 5-6 mg once weekly; mTORC2-sparing weekly pulse vs daily transplant dose - **Rapamycin advanced:** 0.1-0.4 mg/kg cycling per Kaeberlein protocol — requires lipid + immune monitoring ### Safety — long-term tail risks differ sharply Metformin is one of the safest drugs in clinical use. 60+ years of post-market data. Main side effect: GI upset (diarrhea, nausea, metallic taste) in 10-25% of new users, usually fading within 2-4 weeks. Long-term: B12 depletion (supplement 500-1000 mcg/day cyanocobalamin or methylcobalamin). Rare but serious: lactic acidosis (incidence ~1 in 30,000 patient-years), almost always tied to renal insufficiency. Rapamycin's safety story is more nuanced. At immunosuppression doses: increased infection risk, mouth sores, lipid elevation (LDL +20-40%), hyperglycemia, peripheral edema. At PEARL longevity doses (5-10 mg/week): trial showed acceptable safety in healthy adults over 1 year, but long-term effects on immune function in healthy populations are unknown. Both drugs require ongoing labs — metformin: B12 + creatinine annually; rapamycin: lipid panel + glucose + CBC quarterly. - **Metformin common:** GI upset (10-25%), metallic taste, transient appetite reduction - **Metformin long-term:** B12 depletion (supplement); rare lactic acidosis risk in renal insufficiency - **Rapamycin common:** Mouth sores, mild lipid elevation, occasional acne (at weekly doses) - **Rapamycin long-term:** Unknown long-term effects in healthy populations; quarterly labs recommended ### Cost — pennies vs dollars per day Metformin is one of the cheapest drugs in medicine. Generic IR retails $4-15/month at WalMart, CostCo, or any major US pharmacy; extended-release Glucophage XR runs $20-50/month. Insurance covers it universally for T2D + prediabetes; off-label longevity use is typically out-of-pocket. Rapamycin (sirolimus) is significantly more expensive even at the lower weekly dose. Generic sirolimus retail $50-200/month for the 1-2 mg/day equivalent; compounded weekly-dose pulses run $80-150/month. Telehealth longevity clinics (AgelessRx, Healthspan, Lifeforce) markup to $200-400/month including consultation. Off-label coverage is essentially never available. - **Metformin generic:** $4-15/month IR, $20-50/month XR — covered universally for T2D - **Rapamycin generic:** $50-200/month at weekly longevity dose; rarely covered off-label - **Telehealth longevity:** Rapamycin via AgelessRx/Healthspan: $200-400/mo all-in ### Who chooses which — and why most stack them Metformin is the right starting point for almost everyone interested in geroprotection: cheap, safe, decades of human data, and works on the same pathways most insulin-sensitivity protocols already target. The case for rapamycin is stronger mechanistic evidence + the only drug class with consistent mouse-lifespan extension across labs — but human data is thinner and the safety tail is less mapped. Most active longevity protocols (Attia, Sinclair, Kaeberlein) stack them: metformin daily 500-1000 mg + rapamycin 5-6 mg once weekly. The combination covers both AMPK + mTORC1 pathways and amplifies autophagy more than either alone. CAUTION: stacking does increase aggregate immune-modulation, so labs (CBC, lipids, glucose) are non-negotiable. ## Frequently asked ### What's the difference between Metformin and Rapamycin? Metformin is a metabolic that metformin's molecular mechanism of action has been progressively elucidated over decades and now involves multiple overlapping pathways, though which pathway dominates in any given…. Rapamycin is a longevity that rapamycin's mechanism of action centers on its inhibition of the mechanistic target of rapamycin (mtor), a central serine-threonine kinase that integrates nutrient, growth factor,…. The two differ in mechanism, half-life (not reported vs not reported), and typical dose range. ### Which has the longer half-life, Metformin or Rapamycin? Metformin has a half-life of not reported. Rapamycin has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics. ### Can you stack Metformin and Rapamycin? Stacking depends on mechanism overlap, safety profile, and goals. Metformin and Rapamycin should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds. ### Is rapamycin actually proven to extend lifespan in humans? Not yet. The mouse data is the strongest in geroscience — +9-26% median lifespan across NIA ITP studies, replicable across labs. But the only formal human RCT (PEARL, 2023, 130 adults, 1 year) measured safety + biomarkers + physical performance, not lifespan. A formal human lifespan trial would need decades + thousands of participants and doesn't currently exist. Geroscience consensus: mouse data is suggestive but not proof. ### Can I take metformin and rapamycin together? Yes — this is the most common longevity stack (Attia, Sinclair, Kaeberlein protocols). Metformin daily 500-1000 mg + rapamycin 5-6 mg once weekly. They hit different points in the same pathway (AMPK + mTORC1) and have additive autophagy effects. No major drug-drug interaction concerns. Get quarterly labs while stacking: CBC, lipid panel, fasting glucose, creatinine, B12. ### Why is rapamycin dosed once weekly for longevity but daily for transplants? Daily rapamycin inhibits BOTH mTORC1 (the longevity-relevant target) and mTORC2 (which controls insulin signaling + glucose metabolism). Chronic mTORC2 inhibition is what drives the metabolic side effects in transplant patients (hyperglycemia, lipid elevation). Weekly pulse dosing — 5-6 mg every 7 days — inhibits mTORC1 enough to trigger autophagy benefits while letting mTORC2 recover between doses. PEARL trial data supports this approach as safe over 1 year. ### What's the deal with metformin blunting exercise adaptations? A 2019 study (Konopka et al., Aging Cell) showed metformin reduced mitochondrial respiration improvements in older adults doing aerobic training. The effect is modest (~20% reduction in some adaptation markers) and may not apply to younger users or strength training. Practical workaround for longevity users who train hard: take metformin on non-training days, or split the dose so the post-workout window is metformin-free. Other longevity drugs (rapamycin, NMN) don't show this exercise-blunting effect. ### Does rapamycin suppress the immune system? At immunosuppression doses (2-5 mg/day) — yes, that's the indication. At weekly longevity doses (5-6 mg once/week) — minimally per PEARL trial. Some users report slight increase in mouth sores or mild fatigue around dose day. If you're getting frequent infections or wound healing slows visibly, that's a signal to drop the dose or pause. People on chemotherapy, recent surgery, or with chronic infections shouldn't be on longevity-dose rapamycin without physician oversight. ### Is berberine a real metformin substitute? Partially. Berberine also activates AMPK and improves insulin sensitivity, but at ~1/3 the potency of metformin per gram. Typical dose: 500 mg 2-3×/day. Pros: no prescription needed, fewer GI side effects long-term. Cons: weaker glucose-lowering effect (HbA1c reduction ~0.5% vs metformin's ~1.5%), lacks the 60-year safety database. Reasonable choice for users who can't tolerate metformin or want an OTC option, but for confirmed prediabetes or T2D, metformin remains the higher-evidence pick. ## See current vendor prices Live listings from the vendors we track, refreshed continuously. [Metformin prices](/compound/metformin?tab=prices) [Rapamycin prices](/compound/rapamycin?tab=prices) [Compare all compounds](/compare) ### Before you buy Metformin or Rapamycin Check the vendor trust score. Every supplier we track is rated 0–100 on COA verification, payment transparency, shipping, reviews, and listings — one published, reproducible methodology, applied to every vendor including BHG Labs, which shares our ownership. [View Vendor Scorecard](/vendors/scorecard) ## Related comparisons [Berberine vs Metformin](/compare/berberine-vs-metformin)[MOTS C vs SS-31](/compare/mots-c-vs-ss-31)[Methylene Blue vs MOTS C](/compare/methylene-blue-vs-mots-c)[NMN vs NAD](/compare/nmn-vs-nad)[Pinealon vs Epithalon](/compare/pinealon-vs-epithalon)[COQ10 vs NMN](/compare/coq10-vs-nmn)[Urolithin A vs NMN](/compare/urolithin-a-vs-nmn)[Astaxanthin vs COQ10](/compare/astaxanthin-vs-coq10) **Research use only.** BodyHackGuide is a research and price-comparison reference. BodyHackGuide and BHG Labs share common ownership. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See [editorial standards](/editorial-standards) and [affiliate disclosure](/affiliate-disclosure). ![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp) ### BodyHackGuide Your biohacking research hub — compound pricing, brain health protocols, dosing tools, and vendor reviews. [support@bodyhackguide.co](mailto:support@bodyhackguide.co) [](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide)[](https://x.com/bodyhackguide) Explore #### Explore - [Compare prices](/compare) - [Research suppliers](/vendors) - [Deals](/deals) - [Coupons](/coupons) - [Nootropics](/nootropics) - [Brain health](/brain-health) - [Blog](/blog) - [Guides](/guides) Tools #### Tools - [Reconstitution](/tools/reconstitution) - [Dosage calculator](/tools/dosage) - [Half-life visualizer](/tools/halflife) - [COA lookup](/tools/coa) - [Cost calculator](/tools/cost-calculator) - [Stack builder](/stack-builder) - [All tools →](/tools) Trust & vendors #### Trust & vendors - [Vendor directory](/vendors) - [Trust scorecard](/vendors/scorecard) - [Get BHG verified](/vendors/get-vetted) - [Scoring methodology](/vendors/methodology) - [Peptide cheatsheet](/guides/peptide-cheat-sheet-download) Company #### Company - [About](/about) - [Affiliate disclosure](/affiliate-disclosure) - [Editorial standards](/editorial-standards) - [Creators](/creators) - [Coaches](/coaches) - [Privacy](/privacy) - [Terms](/terms) - [Full site directory →](/site-directory) **Ownership & Affiliate Disclosure:** BodyHackGuide and BHG Labs share common ownership. We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy) [Shop BHG Labs · 20% off with BHG20](https://bhglabs.co/shop/?utm_source=reddit&utm_medium=paid&utm_campaign=bhg20_bridge&utm_content=sticky_mobile_bar&ref=zmgqyxku&coupon=BHG20) hi 👋